Musculoskeletal conditions, acute low back pain (lumbago), cervical torticollis (stiff neck), and sports-related sprains represent the single largest volume category in outpatient orthopedic and physiotherapy clinics. The common denominator across all these conditions is the debilitating pain-spasm-pain reflex: trauma causes tissue damage, which induces painful muscle guarding and spasm, which in turn compresses local capillaries, causing further ischemic pain.
Oral muscle relaxants and NSAIDs often cause drowsiness, sedation, and gastric ulcers. Diclofenac Diethylamine 1.16% + Thiocolchicoside 0.125% Emulgel represents the gold-standard prescription topical therapy, delivering targeted analgesia and rapid muscle relaxation directly to the affected joint or muscle belly.

1. Dual-Action Pharmacology: Breaking the Pain-Spasm Cycle
The clinical superiority of this formulation rests on five complementary active components:
Musculoskeletal Pain-Spasm Interruption Cascade:
┌─────────────────────────────────┐ ┌─────────────────────────────────┐
│ Diclofenac Diethylamine (1.16%)│ │ Thiocolchicoside (0.125%) │
│ (Targeted COX-2 Inhibition) │ │ (Myorelaxant Glycinergic Agon)│
├─────────────────────────────────┤ ├─────────────────────────────────┤
│ • प्रोस्टाग्लैंडिन E2 को रोकता है│ │ • गाबा और ग्लाइसिन रिसेप्टर्स बाइंडिंग│
│ • जोड़ों की सूजन और दर्द खत्म │ │ • मांसपेशियों की ऐंठन को शांत करता है│
│ • ऊतकों में गहराई तक प्रवेश करता है│ │ • बिना नींद या सुस्ती लाए आराम देता है│
└─────────────────────────────────┘ └─────────────────────────────────┘
- Diclofenac Diethylamine (1.16% w/w, equiv. to 1.0% Diclofenac Sodium): Selectively inhibits cyclooxygenase-2 (COX-2), arresting the synthesis of pro-inflammatory prostaglandins. Formulated as a diethylamine salt, it possesses high lipophilicity that penetrates the cutaneous lipid barrier up to 3 times faster than plain sodium salts.
- Thiocolchicoside (0.125% w/w): A semi-synthetic derivative of the natural glycoside colchicoside. It acts as an agonist at inhibitory strychnine-sensitive glycinergic and GABA-A receptors in the motor pathways, significantly decreasing neuromuscular tone and relaxing hyper-contracted muscles without sedating the patient.
- Linseed Oil (Flaxseed Oil 3.0% w/w): Rich in alpha-linolenic acid, it serves as a natural anti-inflammatory agent and penetration enhancer.
- Methyl Salicylate (10.0% w/w) & Menthol (5.0% w/w): Deliver alternating cold-and-warm counter-irritant sensory stimulation, overriding pain signals at the spinal cord gate (Melzack-Wall Gate Control Theory).

2. Emulgel Technology: Maximum Skin Penetration
Formulating Diclofenac and Thiocolchicoside requires advanced vacuum emulgel homogenization:
- High-Shear Dispersion: Oil-soluble methyl salicylate and linseed oil are emulsified into sub-micron droplets suspended in a neutralized water-soluble carbomer gel.
- Rapid Dermal Transposition: The emulgel vehicle ensures that active molecules penetrate deep into synovial fluid and muscle fascia rather than sitting atop the epidermis.
- Non-Sticky Elegant Texture: Rubs in smoothly within 30 seconds, leaving skin dry, non-greasy, and pleasant-smelling.

3. Commercial Packaging & Brand Specifications
| Packaging Parameter | Specification Standard |
|---|---|
| Commercial Pack Sizes | 30 g collapsible tubes |
| Tube Construction | 99.7% pure aluminum collapsible tube with interior epoxy lacquer or laminated barrier tube |
| Closure & Nozzle | Membrane-sealed nozzle with HDPE spiked stand-up cap |
| Secondary Packaging | 350 GSM Drip-Off UV embossed monocarton with holographic branding |
| Minimum Order Quantity (MOQ) | Starting from 5,000 tubes per production run |
4. Analytical Quality Control & Pharmacopoeial Release
Every batch manufactured at Saar Biotech’s Baddi facility undergoes complete testing:
- HPLC Dual Assay: Quantifying Diclofenac Diethylamine (90.0% to 110.0%) and Thiocolchicoside (90.0% to 110.0%).
- Rheological Stability & Viscosity: Evaluated via Brookfield rotational viscometer to ensure smooth extrusion across temperature extremes ($4^\circ\text{C}$ to $40^\circ\text{C}$).
- Microbial Limit Testing: Total aerobic count $< 100,\text{CFU/g}$; confirmed absence of pathogens.
Explore related pain management products in our catalog: Diclofenac + Thiocolchicoside Gel and Diclofenac Diethylamine Gel.
For third-party manufacturing quotes, technical dossiers, or pilot batch samples of Diclofenac + Thiocolchicoside Gel, contact our orthopedic formulations desk at quotation@saarbiotech.com or submit your brief through the B2B Project Planner.